# Laser-Enhanced Biomorphic Scaffolds Support Multipotent Stem Cell Differentiation and Angiogenesis for Vascularised Bone Regeneration

**Authors:** Sandeep Kumar, Neelam Iqbal, Yahui Pan, Evangelos Daskalakis, Heather Elizabeth Owston, El Mostafa Raif, Payal Ganguly, Sarathkumar Loganathan, Peter V. Giannoudis, Animesh Jha

PMC · DOI: 10.3390/jfb17020062 · 2026-01-26

## TL;DR

Laser-modified GreenBone scaffolds support stem cell differentiation and blood vessel growth, improving bone regeneration.

## Contribution

Laser drilling of biologically derived scaffolds enhances stem cell behavior and vascularization for bone tissue engineering.

## Key findings

- Laser-drilled GreenBone scaffolds support high cell viability and adhesion of stem cells.
- BMMSCs and cMSCs showed enhanced osteogenic and angiogenic gene expression on laser-modified scaffolds.
- Increased VEGF secretion and ECM remodeling markers indicate active tissue regeneration potential.

## Abstract

Biomorphic hydroxyapatite scaffolds derived from rattan wood (GreenBone) show significant promise in bone tissue engineering due to their inherent structural similarity to natural bone. Laser-drilled GreenBone scaffolds were studied for enhanced porosity, nutrient diffusion, cellular infiltration, and vascularisation. Patient-derived bone marrow mesenchymal stromal/stem cells (BMMSCs) and culture-expanded mesenchymal stem cells (cMSCs) demonstrated high cell viability (>90%), considerable adhesion, and extensive cytoskeletal organisation. Trilineage differentiation confirmed the multipotency of BMMSCs, with osteogenic, adipogenic, and chondrogenic markers being successfully expressed. BMMSCs and cMSCs exhibited enhanced differentiation and gene expression profiles. At week 4, key osteogenic and angiogenic genes such as BMP2, VEGFC, RUNX2, and COL1A1 showed elevated expression, indicating improved bone formation and vascularisation activity. Markers associated with extracellular matrix (ECM) remodelling, including MMP9 and TIMP1, were also upregulated, suggesting active tissue remodelling. ELISA analysis for VEGF further demonstrated increased VEGF secretion, highlighting the scaffold’s angiogenic potential. The improved cellular response and vascular signalling emphasise the translational relevance of laser-modified GreenBone scaffolds for bone tissue engineering, particularly for critical-sized defect repair requiring rapid vascularised bone regeneration.

## Linked entities

- **Genes:** BMP2 (bone morphogenetic protein 2) [NCBI Gene 650], VEGFC (vascular endothelial growth factor C) [NCBI Gene 7424], RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076]

## Full-text entities

- **Genes:** TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, SPARC (secreted protein acidic and cysteine rich) [NCBI Gene 6678] {aka BM-40, OI17, ON, ONT}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, FABP4 (fatty acid binding protein 4) [NCBI Gene 2167] {aka A-FABP, AFABP, ALBP, HEL-S-104, aP2}, HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, FGFR1 (fibroblast growth factor receptor 1) [NCBI Gene 2260] {aka BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1}, VEGFC (vascular endothelial growth factor C) [NCBI Gene 7424] {aka Flt4-L, LMPH1D, LMPHM4, VRP}, CAT (catalase) [NCBI Gene 847], COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}
- **Diseases:** Trauma (MESH:D014947), inflammatory (MESH:D007249), fracture (MESH:D050723), tibial plateau fractures (MESH:D000092463), bone defect (MESH:D001847), toxicity (MESH:D064420)
- **Chemicals:** Water (MESH:D014867), apatite (MESH:D001031), methylene blue (MESH:D008751), Ca3(PO4)2 (MESH:C485817), Oil Red O (MESH:C011049), ethanol (MESH:D000431), Alcian Blue (MESH:D000423), trypan blue (MESH:D014343), P (MESH:D010758), O (MESH:D010100), Phalloidin (MESH:D010590), EDTA (MESH:D004492), Triton X-100 (MESH:D017830), Carbon (MESH:D002244), CO2 (MESH:D002245), alcohol (MESH:D000438), H (MESH:D006859), formaldehyde (MESH:D005557), 4',6-diamidino-2-phenylindole (MESH:C007293), Magnesium (MESH:D008274), Sr (MESH:D013324), ice (MESH:D007053), Ca (MESH:D002118), DPBS (-), Alizarin Red (MESH:C010078), aluminium (MESH:D000535), hydroxyapatite (MESH:D017886), Alexa Fluor  488 (MESH:C000711379)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** G292 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_2909)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942406/full.md

---
Source: https://tomesphere.com/paper/PMC12942406